SLC10A2 and Alagille syndrome: Drugs of the ileal bile acid transporter inhibitor (IBAT) class such as maralixibat and odevixibat have been very successfully introduced in the treatment of PFIC and Alagille’s syndrome with a reduction in symptomatology if not disease progression [44].